Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01450631 · ClinicalTrials.gov registry record · NA
The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions
A NA study, sponsored by KCI USA.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT01450631: Completed NA study, sponsored by KCI USA.
NCT01450631 is a NA study that has completed, run by KCI USA. The registered enrollment target is 92 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01450631, a NA study, has completed, sponsored by KCI USA.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the post-surgical standard-of-care dressing to the Prevena™ Incision Management System in women undergoing Cesarean section surgery.
Primary Outcome
Incidence of postoperative surgical site occurrences (SSOs) post Cesarean section surgery. SSOs include: * Unanticipated local inflammatory response * Prolonged drainage * Fluid collection * Dehiscence * Surgical site infection (SSI)
Interventions
- DEVICE Prevena™ Incision Management System (PIMS)
- DEVICE Standard-of-care Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01450631 record still lists
NCT01450631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Prevena™ Incision Management System (PIMS) is the first listed.
NCT01450631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01450631 about?
NCT01450631 is a clinical study titled "The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions". The purpose of this study is to compare the post-surgical standard-of-care dressing to the Prevena™ Incision Management System in women undergoing Cesarean section surgery.
What is the current status of trial NCT01450631?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2012-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01450631?
The interventions under investigation include: Prevena™ Incision Management System (PIMS) (DEVICE), Standard-of-care Dressing (DEVICE).
Who is sponsoring clinical trial NCT01450631?
This trial is sponsored by KCI USA, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01450631's enrollment target sits among peer trials
92 937th of 2000 higher than 1,062 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia